Clinical Outcomes of Patients with Multiple Myeloma after Daratumumab Failure.

Life (Basel) · 2023 · PMC10532632 · PMID 37763245

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In this line, patients previously exposed to PI presented worse survival in our series (median OS 12 months), and patients previously exposed to lenalidomide showed a trend towards worsened outcomes (median OS 14 months), although the difference was not statistically significant probably due to low statistical power.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.